Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Cash & Current Investments (2020 - 2025)

Bio Essence has reported Cash & Current Investments over the past 6 years, most recently at $28741.0 for Q3 2025.

  • For Q3 2025, Cash & Current Investments fell 9.67% year-over-year to $28741.0; the TTM value through Sep 2025 reached $28741.0, down 9.67%, while the annual FY2024 figure was $3371.0, 2857.02% up from the prior year.
  • Cash & Current Investments for Q3 2025 was $28741.0 at Bio Essence, up from $2000.0 in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $31818.0 in Q3 2024 and troughed at $89.0 in Q3 2023.
  • A 5-year average of $7171.1 and a median of $1286.0 in 2022 define the central range for Cash & Current Investments.
  • Biggest five-year swings in Cash & Current Investments: crashed 98.53% in 2022 and later soared 35650.56% in 2024.
  • Year by year, Cash & Current Investments stood at $303.0 in 2021, then soared by 1966.67% to $6262.0 in 2022, then plummeted by 98.18% to $114.0 in 2023, then surged by 2857.02% to $3371.0 in 2024, then skyrocketed by 752.6% to $28741.0 in 2025.
  • Business Quant data shows Cash & Current Investments for BIOE at $28741.0 in Q3 2025, $2000.0 in Q1 2025, and $3371.0 in Q4 2024.